Bennett D. Elzey

4.9k total citations · 1 hit paper
80 papers, 3.8k citations indexed

About

Bennett D. Elzey is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bennett D. Elzey has authored 80 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 29 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Bennett D. Elzey's work include Immune Cell Function and Interaction (17 papers), Immunotherapy and Immune Responses (13 papers) and Immune cells in cancer (13 papers). Bennett D. Elzey is often cited by papers focused on Immune Cell Function and Interaction (17 papers), Immunotherapy and Immune Responses (13 papers) and Immune cells in cancer (13 papers). Bennett D. Elzey collaborates with scholars based in United States, France and South Korea. Bennett D. Elzey's co-authors include Timothy L. Ratliff, Scott A. Crist, Daniel L. Sprague, Robert J. Jensen, Sandra Torregrosa‐Allen, Thomas S. Griffith, Bernhard Nieswandt, Thomas J. Waldschmidt, Cansu Cimen Bozkus and Stephen F. Konieczny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Bennett D. Elzey

77 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy

2023 127 citations Yun Chang, Ramizah Syahirah et al. profile →

Peers

Countries citing papers authored by Bennett D. Elzey

Since Specialization

Citations

This map shows the geographic impact of Bennett D. Elzey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bennett D. Elzey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bennett D. Elzey more than expected).

Fields of papers citing papers by Bennett D. Elzey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bennett D. Elzey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bennett D. Elzey. The network helps show where Bennett D. Elzey may publish in the future.

Co-authorship network of co-authors of Bennett D. Elzey

This figure shows the co-authorship network connecting the top 25 collaborators of Bennett D. Elzey. A scholar is included among the top collaborators of Bennett D. Elzey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bennett D. Elzey. Bennett D. Elzey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Supinoxin blocks small cell lung cancer progression by inhibiting mitochondrial respiration through DDX5 2025 ·iScience ·Subhadeep Das, (unknown), (unknown), Zheng Xing, Sandra Torregrosa‐Allen, (unknown), (unknown), Bennett D. Elzey, Elizabeth Tran	4
2	Intrapulmonary Spreading of Pharyngeally Instilled Liquids: Impact of Nanoparticle Concentration and PEG Lubrication in Polymer Lung Surfactant Solutions 2025 ·Molecular Pharmaceutics ·(unknown), (unknown), Sandra Torregrosa‐Allen, Xiaoling Jin, Sang-Yoon Kim, Hye Jin Oh, Seon Yeop Jung, Bennett D. Elzey, Seyoung Kim, You‐Yeon Won	0
3	DNA Origami‐Cyanine Nanocomplex for Precision Imaging of KRAS‐Mutant Pancreatic Cancer Cells 2025 ·Advanced Science ·(unknown), (unknown), (unknown), (unknown), (unknown), Bennett D. Elzey, Jong Hyun Choi, Bumsoo Han	2
4	Radiation-induced photodynamic therapy using calcium tungstate nanoparticles and 5-aminolevulinic acid prodrug 2023 ·Biomaterials Science ·(unknown), Sung‐Ho Shin, Jin Yoo, Sandra Torregrosa‐Allen, (unknown), (unknown), Bennett D. Elzey, You‐Yeon Won	3
5	Changes in lipid profile and SOX-2 expression in RM-1 cells after co-culture with preimplantation embryos or with deproteinated blastocyst extracts 2022 ·Molecular Omics ·Nicolás M. Morato, (unknown), Wen‐Hung Wang, Bennett D. Elzey, Gregory M. Cresswell, Bruce R. Cooper, Christina R. Ferreira	1
6	Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells 2022 ·Biomaterials ·Yun Chang, Ramizah Syahirah, Stephanie N. Oprescu, Xuepeng Wang, (unknown), Scott Cooper, Sandra Torregrosa‐Allen, Bennett D. Elzey, Alan Y. Hsu, Lauren N. Randolph, Yufei Sun, Shihuan Kuang, Hal E. Broxmeyer, Qing Deng, Xiaojun Lian, Xiaoping Bao	14
7	BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression 2020 ·Cancer Research ·Aktan Alpsoy, Sagar M. Utturkar, Benjamin C. Carter, Alisha Dhiman, Sandra Torregrosa‐Allen, (unknown), Bennett D. Elzey, Emily C. Dykhuizen	57
8	Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer 2020 ·Cancer Research ·(unknown), Shuyi Fang, (unknown), Sheng Liu, Xufeng Chen, Qingfu Zhang, (unknown), Xuehong Deng, (unknown), Jiaoti Huang, Chenglong Li, Роберто Пили, Bennett D. Elzey, Timothy L. Ratliff, Jun Wan, Chang‐Deng Hu	28
9	Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs 2020 ·Cancer Research ·Gregory M. Cresswell, Bingbing Wang, (unknown), (unknown), (unknown), Renee E. Vickman, Dimiter S. Dimitrov, Sumith A. Kularatne, Chandru P. Sundaram, Sunil Singhal, Evgeniy Eruslanov, Scott A. Crist, Bennett D. Elzey, Timothy L. Ratliff, Philip S. Low	56
10	Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1–Dependent Immune Evasion 2019 ·Cancer Research ·Yi Yang, (unknown), (unknown), Nadia A. Lanman, (unknown), Brett P. Monia, Alexey S. Revenko, Joseph S. Palumbo, Eric S. Mullins, Bennett D. Elzey, Edith M. Janssen, Stephen F. Konieczny, Matthew J. Flick	60
11	Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy 2018 ·Clinical Cancer Research ·Ashley Orillion, Nur P. Damayanti, Li Shen, Remi Adelaiye‐Ogala, Hayley C. Affronti, May Elbanna, Sreenivasulu Chintala, Michael J. Ciesielski, Luigi Fontana, Chinghai Kao, Bennett D. Elzey, Timothy L. Ratliff, David E. Nelson, Dominic J. Smiraglia, Scott I. Abrams, Роберто Пили	85
12	Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway 2018 ·Molecular Cancer Research ·Hyeon Jeong Lee, Jie Li, Renee E. Vickman, Junjie Li, Rui Liu, (unknown), Bennett D. Elzey, Shuhua Yue, Xiaoqi Liu, Timothy L. Ratliff, Ji‐Xin Cheng	72
13	Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma 2017 ·Clinical Cancer Research ·Ashley Orillion, Ayumi Hashimoto, Nur P. Damayanti, Li Shen, Remi Adelaiye‐Ogala, Sreevani Arisa, Sreenivasulu Chintala, Peter Ordentlich, (unknown), Bennett D. Elzey, Dmitry I. Gabrilovich, Роберто Пили	291
14	Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice 2016 ·The Journal of Experimental Medicine ·Pengpeng Bi, Feng Yue, Anju Karki, Beatriz Castro, Sara E. Wirbisky, Chao Wang, (unknown), Bennett D. Elzey, Ourania Andrisani, Christopher A. Bidwell, Jennifer L. Freeman, Stephen F. Konieczny, Shihuan Kuang	78
15	Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer 2012 ·Molecular Cancer Therapeutics ·Bing Song, X. Shawn Liu, (unknown), Shihuan Kuang, Bennett D. Elzey, Stephen F. Konieczny, Timothy L. Ratliff, Tony R. Hazbun, E. Gabriela Chiorean, Xiaoqi Liu	62
16	Plasmacytoid Dendritic Cell-Derived IFN-α Induces TNF-Related Apoptosis-Inducing Ligand/Apo-2L-Mediated Antitumor Activity by Human Monocytes Following CpG Oligodeoxynucleotide Stimulation 2003 ·The Journal of Immunology ·Troy J. Kemp, Bennett D. Elzey, Thomas S. Griffith	58
17	Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness 2002 ·The Journal of Immunology ·Thomas A. Ferguson, John M. Herndon, Bennett D. Elzey, Thomas S. Griffith, (unknown), Douglas R. Green	163
18	Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (alvac) cytokine gene delivery induces destruction of established prostate tumors 2001 ·International Journal of Cancer ·Bennett D. Elzey, D. Robert Siemens, Timothy L. Ratliff, David M. Lubaroff	65
19	Cutting Edge: Restoration of the Ability to Generate CTL in Mice Immune to Adenovirus by Delivery of Virus in a Collagen-Based Matrix 2001 ·The Journal of Immunology ·D. Robert Siemens, Bennett D. Elzey, David M. Lubaroff, (unknown), Robert J. Jensen, (unknown), Timothy L. Ratliff	46
20	Regulation of Fas Ligand-Induced Apoptosis by TNF 2001 ·The Journal of Immunology ·Bennett D. Elzey, Thomas S. Griffith, John M. Herndon, (unknown), Jürg Tschopp, Thomas A. Ferguson	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact